+86-394-7888163 
Established in 2021, Dancheng Huatai Biotechnology Co., Ltd. has a 20,000 square meters of modern production plant and is equipped with complete production and testing apparatus; owing to strictly implement the quality assurance system of ISO9001-2000, the production process and product quality of our company have reached international excellence level successfully.
Now, our company is mainly committed to the research, development and production of APIs and new pharmaceutical intermediates, and has successfully formed a manufacturing capacity of small-scale, pilot-scale and industrial-scale production. At the same time, we also offer a series of services such as research and development of new pharmaceutical intermediates, technology transfer and technical services, etc. We establish laboratories and R&D center through cooperating with well-known chemical research institutions.
Up to now, our company has successfully completed the R&D, pilot trials and production of more than 2,000 kinds of pharmaceutical intermediates and dozens of APIs, and then have formed several product systems-heterocycles (piperidine series, pyrrolidine series, piperazine series, imidazole series, thiazole series, pyrimidine series, indole series, etc.), cyclohexylamines, boric acids, phenylacetylenes and amino acids, etc.
